Photodynamic therapy: At the doorstep of clinical application in widespread dermatoses;Die photodynamische Therapie an der Schwelle zur klinischen Anwendung bei disseminierten Dermatosen

Hautarzt

Volumn 47, Issue 11, 1996, Pages 825-831

  Boehncke, Wolf Henning ^a   Kaufmann, Roland ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

lymphoma; photochemotherapy; photodynamic therapy; psoriasis

Indexed keywords

METHOXSALEN; PHOTOSENSITIZING AGENT;

B LYMPHOCYTE; HUMAN; KERATINOCYTE; LYMPHOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PSORIASIS; PUVA; REVIEW; SKIN DISEASE; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PHOTOCHEMOTHERAPY; PSORIASIS; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0029806749     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050515     Document Type: Review

References (48)

1. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL (1993) Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 51:5993-5996
2. Baumgartner R, Kriegmair M, Knuechel R, Stepp H, Heil P, Hofstetter A (1993) Delta-ALA-assisted fluorescence detection of cancer in the urinary bladder. In: Cubbedu R, van den Bergh H, Svanberg S (eds) Optical instrumentation for biopsy. Proc SPIE 2081: 74-80
3. Ben-Hur E, Heldman E, Crane SW, Rosenthal I (1988) Release of clotting factor(s) from cultured endothelial cells photosensitized by photodynamic therapy. Laser Med Sci (Abstract Issue): 107
4. Berns MW, Rettenmaier M, McCullough J, Coffey J, Wile A, Berman M, DiSaia P, Weinstein G (1984) Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivate. Lasers Surg Med 4: 73-77
5. Boehncke W-H, König K, Kaufmann R, Scheffold W, Prümmer O, Sterry W (1994) Photodynamic therapy in psoriasis: Suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 286: 300-303
6. Boehncke W-H, Rück A, Naumann J, Sterry W, Kaufmann R (1996) Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infil-trating cell types in vitro. Lasers Surg Med (in press)
7. Boehncke W-H, Sterry W, Kaufmann R (1994) Successfull treatment of psoriasis by topical photodynamic therapy using polychromatic light. Lancet 343: 801
8. Breider MA, Lu X, Panjehpour M, Frazier DL (1993) Cytokine modulation of endothelial cell sensitivity to photodynamic therapy. Lasers Surg Med 13:-305-311
9. Diezel W, Meffert H, Sönnichsen N (1980) Therapy of psoriasis with hematoporphyrin derivate and light. Dermatol Monatsschr 166: 599
10. Dougherty TJ, Cooper MT, Mang TS (1990) Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 10: 485-488
11. Dougherty TJ, Henderson BW, Schwartz S, Winkelman JW, Lipson RL (1992) Historical perspective. In: Henderson BW, Dougherty TJ (Hrsg) Photodynamic therapy: basic principles and clinical applications. Dekker New York, pp 1-15
12. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38: 2628-2635
13. Elmets CA, Bowen KD (1986) Immunological suppression in mice treated with hematoporphyrin derivate photoradiation. Cancer Res 46: 1608-1611
14. Emtestam L, Berglund L, Angelin B (1989) Tin-protoporphyrin and long wavelength ultraviolet light in treatment of psoriasis. Lancet I: 1231-1233
15. Evans S, Mathews W, Perry R, Fraker J, Norton J, Pass HI (1990) Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst 82: 34-39
16. Gomer CJ, Rucker N, Murphree AL (1988) Transformation and mutagenic potential of porphyrin photodynamic therapy in mammalian cells. Int J Radiat Biol 53: 651-659
17. Haranaka K (1988) Tumor necrosis factor: how to improve the antitumor activity and decrease accompanying side effects for therapeutic application. J Biol Response Mod 7: 525-535
18. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
19. Henderson BW, Waldow SM, Mang SM, Dougherty TS (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45: 572-576
20. Jori G, Reddi E (1990) Strategies for tumor targeting by photodynamic sensitizers. In: Kessel D (Hrsg) Photodynamic therapy of neoplastic disease. CRC Press, Boca Raton 2: 117-130
21. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6: 143-148
22. Krutmann J, Athar M, Khan UI, Mendel D, Guyre PM, Mukhtar H, Elmets CA (1989) Inhibition of the high affinity Fcreceptor (FcgammaRI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J Biol Chem 264: 11407-11413
23. Landthaler M, Rück A, Szeimies R-M (1993) Photodynamische Therapie von Tumoren der Haut. Hautarzt 44: 69-74
24. Levy JG (1994) Photosensitizers in photodynamic therapy. Semin Oncol 21: S4-S10
25. Lin CW (1990) Selective localization of photosensitizers in tumors: a review of the phenomenon and possible mechanisms. In: Kessel D (Hrsg) Photodynamic therapy of neoplastic disease. CRC Press, Boca Raton 2: 79-101
26. Lipson RL, Baldes EJ, Olsen AM (1961) The use of a derivate of hematoporphyrin in tumor detection. J Natl Cancer Inst 26: 1-11
27. Lui H, Anderson RR (1992) Photodynamic therapy in dermatology: shedding a different light on skin disease. Arch Dermatol 128: 1631-1636
28. Mc Caughan JS, Guy JT, Hawley P et al (1983) Hematoporphyrin- derivate and photoradiation therapy of malignant tumors. Lasers Surg Med 3: 199-209
29. McKenzie AL, Carruth JAS (1986) A comparison of gold-vapour and dye lasers for photodynamic therapy. Lasers Med Sci 1: 117-120
30. Moan J, Peng Q, Evensen JF, Berg K, Western A, Rimington C (1987) Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 46: 713-721
31. Mukhtar H, Zaidi SIA, Bickers DR, Elmets CA (1995) Photoimmunology in photodynamic therapy. In: Krutmann J, Elmets CA (eds) Photoimmunology. Oxford, pp 257-264
32. Musser DA, Fiel RJ (1991) Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol 53: 119-123
33. Panjehpour M, Overholt BF, DeNovo RC, Petersen MG, Sneed RE (1993) Comparative study between pulsed and continuous wave lasers for Photofrin photodynamic therapy. Lasers Surg Med 13: 296-304
34. Pres H, Meffert H, Sönnichsen N (1989) Photodynamic therapy of psoriasis palmaris et plantaris using a topically ap-plied hematoporphyrin derivate and visible light. Dermatol Monatsschr 175: 745-750
35. Ramakrishnan N, Oleinick NL, Clay ME, Horng MF, Antunez AR, Evans HH (1989) DNA lesions and DNA degradation in mouse lymphoma L5178Y cells after photodynamic treatment sensitized by chloroaluminium phthalocyanine. Photochem Photobiol 50: 373-378
36. Razum N, Balchum OJ, Profio AE, Carstens F (1987) Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivates, HpD and DHE. Photochem Photobiol 46: 925-928
37. Rittenhouse-Diakun K, van Leengoed H, Morgan J, Hryhorenko E, Paszkiewicz G, Whitaker JE, Oseroff AR (1995) The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol 61: 523-528
38. Sacchini V, Melloni E, Marchsini R, Luini A, Bandieramonte G, Spinelli P, Cascinelli N (1987) Preliminary clinical studies with PDT by topical TPPS administration in neoplastic skin lesions. Lasers Surg Med 7: 6-11
39. Schick E, Kaufmann R, Rück A, Hainzl A, Boehncke W-H (1995) Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venerol 75: 276-279
40. Shanler SD, Buscaglia DA, van Leengoed E, Wan W, Whitaker JE, Mang TS, Barcos M, Stoll HL, Oseroff AR (1994) PDT with topical delta-aminolevulinic acid for treatment of patch and plaque stage cutaneous T-cell lymphoma. J Invest Dermatol 102: 615
41. Silver H (1937) Psoriasis vulgaris treated with hematoporphyrin. Arch Dermatol Syphilol 36: 1118-1119
42. Star WM, Marijnissen HPA, van den Berg-Blok AE, Versteeg JAC, Fraken KAP, Reinhold HD (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivate photoradiation observed in vitro in sandwich observation chambers. Cancer Res 46: 2532-2540
43. Stern RS (1991) Risks of cancer associated with long-term exposure to PUVA in humans: current status 1991. Blood Cells 18: 91-97
44. Tappenier H, Jesionek A (1903) Therapeutische Versuche mit fluoreszierenden Stoffen. MMW 1: 2042-2044
45. Valenzeno DP (1987) Photomodification of biological membranes with emphasis on singlet oxygen mechanisms. Photochem Photobiol-B 46: 147-160
46. West CML, West DC, Kumar S, Moore JV (1990) A comparison of the sensitivity to photodynamic treatment of endothelial and tumor cells in different proliferative states. Int J Radiat Biol 58: 145-156
47. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ (1992) Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128: 1597-1601
48. Zhou CN (1989) Mechanisms of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol-B 3: 299-318